ANRS DATURA and DREAMM, two promising projects to combat opportunistic infections in people living with HIV
Amid the Launch of the GH EDCTP3 Program, ANRS | Emerging Infectious Diseases proposes a closer look at two projects funded as part of EDCTP2.
The European and Developing Countries Clinical Trials Partnership (EDCTP) is a public-public partnership founded in 2003 between European and sub-Saharan African countries, supported by the European Union. Its objective is to support and accelerate the development of clinical trials to enable the deployment of optimal therapeutic strategies against infectious and (re-)emerging diseases, as well as diseases related to poverty, in order to reduce their mortality rates. Over 300 clinical trials had been supported as part of EDCTP2. This partnership also aims to strengthen the infrastructure needed to conduct research, provide better patient care in sub-Saharan Africa, and train young researchers.
"Today we are launching the third EDCTP program, one of the largest research and development partnerships in the history of African-European cooperation. The Global Health EDCTP3 Joint Undertaking (GH EDCTP3) will continue to enable leading African and European researchers to pool their expertise in order to put an end to infectious and (re-)emerging poverty-related diseases, such as HIV/AIDS, tuberculosis, malaria, and neglected tropical diseases.
By investing in the capacity-building of hospital structures and by training medical teams that need and wish to have such training, EDCTP enables the various players to make lasting structural changes within their countries' health systems."
Yazdan Yazdanpanah, Director of ANRS | Emerging Infectious Diseases and Vice-Chair of the EDCTP Board.
By 2030, the GH EDCTP3 program, reinforced by the creation of a joint undertaking between the European Union and the EDCTP Association and consisting of several European and African countries, aims to develop and deploy new technologies to tackle infectious diseases and support at least 100 research institutes in 30 countries.
ANRS | Emerging Infectious Diseases is committed, has contributed to, and continues to be involved in this initiative. Amid the launch of the Global Health EDCTP3 Joint Undertaking hosted in Paris, France by ANRS | Emerging Infectious Diseases on May 10, 2022, the agency is proposing a closer look at two projects co-funded with EDCTP and driven by French teams and African partners as part of EDCTP2 : ANRS DREAMM and DATURA. By working to implement global efforts to advance research into infectious and (re-)emerging diseases, these projects reflect the agency's philosophy and priorities.